Evidence map›Paper›PMID 21799517›Full record

ArticleEMBO reports2011

The E3 ligase c-Cbl regulates dendritic cell activation.

Shin-Heng Chiou, Payam Shahi, Ryan T Wagner, Hongbo Hu, Natalia Lapteva, Mamatha Seethammagari, Shao-Cong Sun, Jonathan M Levitt, David M Spencer

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of Ubiquitin Signaling in Modulating Dendritic Cell Function.Advances in experimental medicine and biology · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Role of E3 ubiquitin ligases in lung cancer.World journal of clinical oncology · 2013
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shin-Heng ChiouDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
Payam Shahi
Ryan T Wagner
Hongbo Hu
Natalia Lapteva
Mamatha Seethammagari
Shao-Cong Sun
Jonathan M Levitt
David M Spencer
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · USBaylor School · US

Funding

MOLECULAR AND CELLULAR MECHANISMS OF HOST DEFENSET32AI007495 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI TAN, TSE-HUA · 1996 to 2011
$2.4M
Enhancement of Dendritic Cells for Improved ImmunotherapyR01CA120411 · NCI · BAYLOR COLLEGE OF MEDICINE · PI SPENCER, DAVID M · 2006 to 2009
$929k
NCI NIH HHS R01 CA120411NCI NIH HHS R01-CA120411NIAID NIH HHS T32 AI007495NIAID NIH HHS T32-AI07495
6 · The paper itself

Abstract

The activation of innate and adaptive immunity is always balanced by inhibitory signalling mechanisms to maintain tissue integrity. We have identified the E3 ligase c-Cbl--known for its roles in regulating lymphocyte signalling--as a modulator of dendritic cell activation. In c-Cbl-deficient dendritic cells, Toll-like receptor-induced expression of proinflammatory factors, such as interleukin-12, is increased, correlating with a greater potency of dendritic-cell-based vaccines against established tumours. This proinflammatory phenotype is accompanied by an increase in nuclear factor (NF)-κB activity. In addition, c-Cbl deficiency reduces both p50 and p105 levels, which have been shown to modulate the stimulatory function of NF-κB. Our data indicate that c-Cbl has a crucial, RING-domain-dependent role in regulating dendritic cell maturation, probably by facilitating the regulatory function of p105 and/or p50.

Indexed as

AnimalsAntigens, NuclearChromosomal Proteins, Non-HistoneDendritic CellsFemaleInterleukin-12MiceMice, Inbred C57BLMice, KnockoutNF-kappa B p50 SubunitProto-Oncogene Proteins c-cblSignal TransductionToll-Like ReceptorsAntigens, NuclearCbl protein, mouseChromosomal Proteins, Non-HistoneInterleukin-12NF-kappa B p50 SubunitProto-Oncogene Proteins c-cblToll-Like Receptors

Identifiers

PMID21799517
PMCPMC3166462
OpenAlexW2105129505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.